数字药丸技术应用中的伦理问题及规制路径OA
Ethical issues and regulatory paths of digital pill technology
数字药丸技术作为一项新兴的数字医疗手段,具有实时监测和改善患者服药依从性的潜在优势.然而,随着其发展与应用,随之而来的伦理困境与挑战也不容忽视,这些挑战包括患者自主性可能被削弱、隐私权被侵犯的风险、医患信任的潜在削弱、数据责任模糊问题、商业模式与公共健康之间的冲突,以及弱势群体在技术获取上的公平性问题.为推动数字药丸技术的规范化和伦理化发展,需要从法律与伦理监管、隐私保护与数据管理、知情同意、责任分配机制、技术公平可及、伦理教育与培训等多方面构建规制路径,以实现技术创新与患者福祉提升之间的有效平衡.
Digital pill technology,as an emerging digital healthcare means,possesses potential advantages of real-time monitoring and improving patient medication adherence.However,with its development and application,the ensuing ethical dilemmas and challenges cannot be overlooked.These challenges include the potential weakening of patient autonomy,the risk of privacy invasion,the potential erosion of doctor-patient trust,the issue of ambiguous data liability,the conflict between business models and public health,and the problem of fairness in technology accessibility for vulnerable groups.To promote the standardization and ethical development of digital pill technology,it is necessary to establish regulatory paths from multiple perspectives,including legal and ethical supervision,privacy protection and data management,informed consent,responsibility allocation mechanism,equitable technology accessibility,and ethical education and training,thereby achieving an effective balance between technological innovation and the enhancement of patient well-being.
胡蝶花;李红文
湖南中医药大学马克思主义学院,湖南 长沙 410208湖南中医药大学马克思主义学院,湖南 长沙 410208
医药卫生
数字药丸服药依从性患者隐私健康数据自主性
digital pillmedication adherencepatient privacyhealth dataautonomy
《中国医学伦理学》 2026 (4)
475-484,10
2024年国家社会科学基金项目"当代中国生命伦理学话语体系构建研究"(24BZX101)2025年湖南省普通本科高校教学改革研究项目"AI赋能《医学伦理学》课程交互式教学模式探究与实践"(202502000647)
评论